Universal Biosensors Inc (ASX:UBI) reported a half-year loss attributable A$2.4 million, compared to a loss of A$9.2 million.
Revenue from ordinary activities down 16% to A$2.6 million.
Universal Biosensors Inc is a biotechnology company.
Supported by
<SPON> Trade share CFDs with Plus500
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Subscribe to the newsletter
Receive whispers every day in your inbox.